OCX stock results show that OncoCyte missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
Articles
XTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q1 2024
XTNT stock results show that Xtant Medical Hldgs missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More
NVGS Stock Earnings: Navigator Holdings Meets EPS, Misses Revenue for Q1 2024
NVGS stock results show that Navigator Holdings met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
SHWZ Stock Earnings: Medicine Man Technologies Misses EPS, Beats Revenue for Q1 2024
SHWZ stock results show that Medicine Man Technologies missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More
VLD Stock Earnings: Velo3D Misses EPS, Misses Revenue for Q1 2024
VLD stock results show that Velo3D missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
AYTU Stock Earnings: Aytu BioPharma Beats EPS, Beats Revenue for Q3 2024
AYTU stock results show that Aytu BioPharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. More
SPIR Stock Earnings: Spire Global Beats EPS, Misses Revenue for Q1 2024
SPIR stock results show that Spire Global beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
